425 related articles for article (PubMed ID: 36010993)
21. Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma.
Liu T; Chen Z; Chen W; Evans R; Xu J; Reeves ME; de Vera ME; Wang C
Precis Clin Med; 2023 Mar; 6(1):pbad004. PubMed ID: 37007745
[TBL] [Abstract][Full Text] [Related]
22. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma.
Lee DU; Han BS; Jung KH; Hong SS
Biomol Ther (Seoul); 2024 May; 32(3):281-290. PubMed ID: 38590092
[TBL] [Abstract][Full Text] [Related]
23. Tumor matrix stiffness provides fertile soil for cancer stem cells.
Safaei S; Sajed R; Shariftabrizi A; Dorafshan S; Saeednejad Zanjani L; Dehghan Manshadi M; Madjd Z; Ghods R
Cancer Cell Int; 2023 Jul; 23(1):143. PubMed ID: 37468874
[TBL] [Abstract][Full Text] [Related]
24. Cancer-Associated Fibroblasts' Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma.
Awaji M; Singh RK
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30832219
[TBL] [Abstract][Full Text] [Related]
25. Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics.
Smigiel JM; Parameswaran N; Jackson MW
Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29320425
[TBL] [Abstract][Full Text] [Related]
26. Tumor⁻Stroma Cross-Talk in Human Pancreatic Ductal Adenocarcinoma: A Focus on the Effect of the Extracellular Matrix on Tumor Cell Phenotype and Invasive Potential.
Procacci P; Moscheni C; Sartori P; Sommariva M; Gagliano N
Cells; 2018 Oct; 7(10):. PubMed ID: 30301152
[TBL] [Abstract][Full Text] [Related]
27. Secretome protein signature of human pancreatic cancer stem-like cells.
Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
[TBL] [Abstract][Full Text] [Related]
28. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG
Front Oncol; 2020; 10():621937. PubMed ID: 33520728
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
[TBL] [Abstract][Full Text] [Related]
30. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.
Carvalho TMA; Di Molfetta D; Greco MR; Koltai T; Alfarouk KO; Reshkin SJ; Cardone RA
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885243
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
[TBL] [Abstract][Full Text] [Related]
32. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer.
Basu M; Philipp LM; Baines JF; Sebens S
Front Oncol; 2021; 11():740606. PubMed ID: 34631577
[TBL] [Abstract][Full Text] [Related]
33. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
Giovannetti E; van der Borden CL; Frampton AE; Ali A; Firuzi O; Peters GJ
Semin Cancer Biol; 2017 Jun; 44():43-59. PubMed ID: 28438662
[TBL] [Abstract][Full Text] [Related]
34. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
Penchev VR; Chang YT; Begum A; Ewachiw T; Gocke C; Li J; McMillan RH; Wang Q; Anders R; Marchionni L; Maitra A; Uren A; Rasheed Z; Matsui W
Mol Cancer Res; 2019 Apr; 17(4):929-936. PubMed ID: 30655325
[TBL] [Abstract][Full Text] [Related]
35. Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities.
Myo Min KK; Ffrench CB; Jessup CF; Shepherdson M; Barreto SG; Bonder CS
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190281
[TBL] [Abstract][Full Text] [Related]
36. Desmoplasia of pancreatic ductal adenocarcinoma.
Pandol S; Edderkaoui M; Gukovsky I; Lugea A; Gukovskaya A
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S44-7. PubMed ID: 19896098
[TBL] [Abstract][Full Text] [Related]
37. The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.
Kudo D; Suto A; Hakamada K
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282922
[TBL] [Abstract][Full Text] [Related]
38. Extracellular matrix: a dynamic microenvironment for stem cell niche.
Gattazzo F; Urciuolo A; Bonaldo P
Biochim Biophys Acta; 2014 Aug; 1840(8):2506-19. PubMed ID: 24418517
[TBL] [Abstract][Full Text] [Related]
39. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
